Diversified Trust’s Aimmune Therapeutics AIMT Stock Holding History

Diversified Trust’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-20,000	Closed	-$689K	–	796
2020 Q3	$689K	Hold	20,000	–	–	0.03%	247
2020 Q2	$334K	Hold	20,000	–	–	0.02%	360
2020 Q1	$288K	Buy	+20,000	New	+$511K	0.02%	301

Diversified Trust's AIMT Position: Q4 2020 in Review

Diversified Trust sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 20,000 shares — an estimated $689K sold.

Diversified Trust first reported a position in AIMT in Q1 2020 and held it in 3 quarters. The position peaked at $689K in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

Diversified Trust reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
Diversified Trust sold 20,000 Aimmune Therapeutics shares in Q4 2020, an estimated $689K.
Diversified Trust first reported a position in Aimmune Therapeutics in Q1 2020 and held it in 3 quarters.
Diversified Trust's Aimmune Therapeutics position peaked at $689K in Q3 2020.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Diversified Trust's 13F filing for Q4 2020, filed 8 Jan 2021.